Clinical Trial
Study Details
Study Overview
This study will test a medicine, NNC6019-0001, for people who have a heart disease due to TTR amyloidosis. It will look at how safe this medicine is in the long term and if it can reduce symptoms of a heart disease due to TTR amyloidosis, such as heart failure. It is an extension to a study called "A research study to look at how a new medicine called NNC6019-0001 works and how safe it is for people who have a heart disease due to TTR amyloidosis". Only participants who have completed that study will be invited for this new study. Participants will get NNC6019-0001, regardless of whether they got placebo or NNC6019-0001 in the first study. The study will last for up to 157 weeks (36 months/3 years).
Contacts and Locations
Mayo Clinic Arizona
Phoenix, Arizona 85054
United States
Cedars-Sinai Medical Center_Los Angeles
Los Angeles, California 90048
United States
Stanford Hlth Cre-Boswell Clin
Stanford, California 94305
United States
Mayo Clinic Jacksonville
Jacksonville, Florida 32224
United States
NW Univ-Bluhm Cardiovasc Inst
Chicago, Illinois 60611
United States
NW Univ-Bluhm Cardiovasc Inst
Evanston, Illinois 60208
United States
Univ of MD Schl of Med
Baltimore, Maryland 21201
United States
Mayo Clinic Rochester
Rochester, Minnesota 55905
United States
University of Calgary_Cardiology
Calgary Alberta T2N 4Z6
Canada
Ctr for Cardiovascular Innovation
Vancouver British Columbia V5Z 1M9
Canada
II. interni klinika VFN - Kardiologie a angiologie
12808 Prague
Czechia
Ap-Hp-Hopital Henri Mondor
94000 Créteil
France
Centre Hospitalier Universitaire de Toulouse-Hopital Rangueil-1
31059 Toulouse
France
UniklinikHeidelberg - Innere Med. III - Kardiologie, Angiologie, Pneumologie
69120 Heidelberg
Germany
Universitätsklinik Heidelberg Innere Medizin III Kardiologie, Angiologie, Pneumologie
69120 Heidelberg
Germany
LMU Klinikum München Klinik und Poliklinik 1
81377 München
Germany
Uniklinik Münster, Klinik für Kardiologie I
48149 Münster
Germany
Universitätsklinikum Münster - Klinik für Kardiologie I
48149 Münster
Germany
Universitatsklinikum Wurzburg AöR
97078 Würzburg
Germany
Universitatsklinikum Würzburg - Zentrum für Herzinsuffizienz
97078 Würzburg
Germany
Fondazione CNR-Regione Toscana Gabriele Monasterio
56124 Pisa Pi
Italy
Fondazione Toscana Gabriele Monasterio - Dipartimento Cardiotoracico - UOC Cardiologia e Medicina Cardiovascolare
56124 Pisa Pi
Italy
Centro per lo Studio e la Cura delle Amiloidosi Sistemiche Fondazione IRCCS Policlinico San Matteo
27100 Pavia PV
Italy
Hospital of the University of Occupational and Environmental Health, Cardiology, Nephrology
Fukuoka
807-8556
Japan
Hiroshima University hospital, Cardiovascular Medicine
Hiroshima
734-8551
Japan
Kumamoto University Hospital, Cardiovascular Medicine
Kumamoto-shi, Kumamoto
860-8556
Japan
Shinshu University Hospital, Department of Neurology
Nagano
390-8621
Japan
Nagasaki University Hospital, Cardiovascular Medicine
Nagasaki
852-8501
Japan
Okayama University Hospital_Cardiovascular Medicine
Okayama-shi, Okayama
700-8558
Japan
UMC Groningen
9713 GZ Groningen
Netherlands
Universitair Medisch Centrum Utrecht
3584 CX Utrecht
Netherlands
Hospital da Senhora da Oliveira - Guimarães
4835-044 Guimarães
Portugal
Unidade Local de Saude do Alto Ave, E.P.E.
4835-044 Guimarães
Portugal
Unidade Local De Saude De Tras-Os-Montes E Alto Douro E.P.E.
5000-508 Vila Real
Portugal
Hospital Universitario Puerta de Hierro Majadahonda
28222 Majadahonda Madrid
Spain